Viktor Fleming
Mannheim, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression.
Journal: British journal of cancer
Published: May 26, 2018
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors.
Journal: Frontiers in immunology
Published: March 30, 2018
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression.
Journal: Frontiers in immunology
Published: November 30, 2017
Editorial: Two MDSC faces in obesity: Correcting metabolic dysfunctions but promoting tumor development.
Journal: Journal of leukocyte biology
Published: October 23, 2017
Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma.
Journal: The Journal of clinical investigation
Published: October 12, 2017
CCR5+ Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions.
Journal: Cancer research
Published: February 02, 2017
Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal-maternal interface.
Journal: Histochemistry and cell biology
Published: December 08, 2016
Myeloid-derived suppressor cells and tumor escape from immune surveillance.
Journal: Seminars in immunopathology
Published: September 28, 2016
Impaired gp100-Specific CD8(+) T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma Model.
Journal: The Journal of investigative dermatology
Published: December 18, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026